Skip to content

Clinical trials

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Country / region: United States Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20051
20081
20091
20111
20122
20131
20142
20153
20161
20171
20181
20192
20203
20213
20225
20232
20243
202513
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting19
Terminated7
Active, not recruiting4
No longer available1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
argenx7
Sanofi4
Takeda4
Immunovant Sciences GmbH3
Baxalta now part of Shire2
CSL Behring2
Grifols Therapeutics LLC2
Rutgers, The State University of New Jersey2
Biogen1
Bioverativ, a Sanofi company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating54
Myasthenia Gravis5
Autoimmune Diseases4
Autoimmune Diseases of the Nervous System3
Multiple Sclerosis3
Neuromyelitis Optica3
Peripheral Nervous System Diseases3
Charcot-Marie-Tooth Disease2
Demyelinating Diseases2
Lambert-Eaton Myasthenic Syndrome2

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.